Home » Topics » Regulatory » Patents

Patents
RSS

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical generate anti-HER2 antibody-drug conjugate

Sep. 5, 2016

Guangzhou Institutes of Biomedicine and Health divulges UCP 1 activators

Sep. 5, 2016

Shanghai De Novo Pharmatech identifies novel IDO1/TDO2 inhibitors

Sep. 5, 2016

Suzhou Zelgen Biosciences presents new farnesoid X receptor agonists

Sep. 5, 2016

Bayer Pharma patents Wnt signaling pathway inhibitors

Sep. 5, 2016

Glucox Biotech describes novel NADPH oxidase 4 inhibitors

Sep. 5, 2016

Incyte announces PI3Kgamma inhibitors

Sep. 2, 2016

Merck & Co. develops retinoid RORgammaT antagonists

Sep. 2, 2016

Enanta Pharmaceuticals describes FXR agonists

Sep. 2, 2016

Genentech and Roche disclose TRPA1 antagonists

Sep. 2, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...